PCSK-9 inhibitors vs. ezetimibe for secondary prevention: utilization disparities and clinical outcomes
31 August 2025 (08:15 - 09:00)
Organised by: 

About the speaker

UAB Hospital, Birmingham (United States of America)
7 More presentations in this session

Miss J. Jannink (Utrecht, NL)
Access the full session
The Event
ESC Congress 2025
31 August 2025
08:15 CET
You may be interested in
Congress Session
1 September 2025

Congress Presentation
30 August 2024

Congress Presentation




